{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:38:32Z","timestamp":1780065512991,"version":"3.54.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1580-5","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T12:42:10Z","timestamp":1525264930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Factors associated with physicians\u2019 prescriptions for rheumatoid arthritis drugs not filled by patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Hong J.","family":"Kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Dyagilev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schulam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchi","family":"Saria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Kharrazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bodycombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles T.","family":"Molta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"1580_CR1","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3899\/jrheum.151212","volume":"43","author":"JR Curtis","year":"2016","unstructured":"Curtis JR, Bykerk VP, Aassi M, Schiff M. Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review. J Rheumatol. 2016;43:1997\u20132009.","journal-title":"J Rheumatol"},{"key":"1580_CR2","doi-asserted-by":"publisher","unstructured":"Sauer BC, Teng CC, Tang D, Leng J, Curtis JR, Mikuls TR, et al. Persistence with conventional triple therapy versus a tumor necrosis factor inhibitor and methotrexate in U.S. veterans with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2017;69(3):313\u201322. https:\/\/doi.org\/10.1002\/acr.22944 .","DOI":"10.1002\/acr.22944"},{"key":"1580_CR3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.clinthera.2011.06.001","volume":"33","author":"MA Blum","year":"2011","unstructured":"Blum MA, Koo D, Doshi JA. Measurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: a systematic review. Clin Ther. 2011;33:901\u201313.","journal-title":"Clin Ther"},{"key":"1580_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12325-015-0256-7","volume":"32","author":"E Vangeli","year":"2015","unstructured":"Vangeli E, Bakhshi S, Baker A, Fisher A, Bucknor D, Mrowietz U, et al. A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases. Adv Ther. 2015;32:983\u20131028.","journal-title":"Adv Ther"},{"key":"1580_CR5","doi-asserted-by":"publisher","first-page":"e000171","DOI":"10.1136\/rmdopen-2015-000171","volume":"2","author":"HF Hope","year":"2016","unstructured":"Hope HF, Bluett J, Barton A, et al. Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomes. RMD Open. 2016;2:e000171. https:\/\/doi.org\/10.1136\/rmdopen-2015-000171 .","journal-title":"RMD Open"},{"key":"1580_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/rheumatology\/keu358","volume":"54","author":"J Bluett","year":"2015","unstructured":"Bluett J, Morgan C, Thurston L, Plant D, Hyrich KL, Morgan AW, et al. Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Rheumatology (Oxford). 2015;54:494\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"1580_CR7","doi-asserted-by":"publisher","unstructured":"Pasma A, Schenk CV, Timman R, et al. Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease. Arthritis Res Ther. 2015;17:281. https:\/\/doi.org\/10.1186\/s13075-015-0801-4 .","DOI":"10.1186\/s13075-015-0801-4"},{"key":"1580_CR8","doi-asserted-by":"publisher","unstructured":"Horne R, Chapman SCE, Forbes A, Parham R, Freemantle N, Cooper V. Understanding patients\u2019 adherence-related beliefs about prescribed medicines: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12) https:\/\/doi.org\/10.1371\/journal.pone.0080633","DOI":"10.1371\/journal.pone.0080633"},{"key":"1580_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1369-7625.2010.00619.x","volume":"14","author":"CA McHorney","year":"2011","unstructured":"McHorney CA, Spain CV. Frequency of and reasons for medication non-fulfillment and non-persistence among American adults with chronic disease in 2008. Health Expect. 2011;14:307\u201320. https:\/\/doi.org\/10.1111\/j.1369-7625.2010.00619.x .","journal-title":"Health Expect"},{"issue":"1","key":"1580_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12891-016-1254-x","volume":"17","author":"JR Curtis","year":"2016","unstructured":"Curtis JR, Xie F, Mackey D, Gerber N, Bharat A, Beukelman T, Saag KG, Chen L, Nowell B, Ginsberg S. Patient's experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis. BMC Musculoskelet Disord. 2016;17(1):405.","journal-title":"BMC Musculoskelet Disord"},{"key":"1580_CR11","doi-asserted-by":"publisher","first-page":"CD007848","DOI":"10.1002\/14651858.CD007848.pub2","volume":"4","author":"JA Singh","year":"2009","unstructured":"Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2009;4:CD007848. https:\/\/doi.org\/10.1002\/14651858.CD007848.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"key":"1580_CR12","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/acr.22244","volume":"66","author":"E Yelin","year":"2014","unstructured":"Yelin E, Tonner C, Kim SC, Katz JN, Ayanian JZ, Brookhart MA, Solomon DH. Sociodemographic, disease, health system, and contextual factors affecting the initiation of biologic agents in rheumatoid arthritis: a longitudinal study. Arthritis Care Res (Hoboken). 2014;66:980\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1580_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.18553\/jmcp.2016.22.3.209","volume":"22","author":"J Harnett","year":"2016","unstructured":"Harnett J, Wiederkehr D, Gerber R, Gruben D, Bourret J, Koenig A. Primary nonadherence, associated clinical outcomes, and health care resource use among patients with rheumatoid arthritis prescribed treatment with injectable biologic disease-modifying antirheumatic drugs. J Manag Care Spec Pharm. 2016;22:209\u201318.","journal-title":"J Manag Care Spec Pharm"},{"key":"1580_CR14","doi-asserted-by":"publisher","unstructured":"Kim SY, Servi A, Polinski JM, et al. Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther 2011;13(1):R32. https:\/\/doi.org\/10.1186\/ar3260 .","DOI":"10.1186\/ar3260"},{"issue":"2","key":"1580_CR15","first-page":"83","volume":"5","author":"R Greenapple","year":"2012","unstructured":"Greenapple R. Trends in biologic therapies for rheumatoid arthritis: results from a survey of payers and providers. Am Health Drug Benefits. 2012;5(2):83\u201392.","journal-title":"Am Health Drug Benefits"},{"key":"1580_CR16","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1377\/hlthaff.2012.0493","volume":"32","author":"P Fronstin","year":"2013","unstructured":"Fronstin P, Sep\u00falveda MJ, Roebuck MC. Consumer-directed health plans reduce the long-term use of outpatient physician visits and prescription drugs. Health Aff (Millwood). 2013;32:1126\u201334.","journal-title":"Health Aff (Millwood)"},{"key":"1580_CR17","unstructured":"Johns Hopkins Bloomberg School of Public Health. The Johns Hopkins ACG\u00ae System, Version 11.0. https:\/\/www.hopkinsacg.org\/ . Accessed Oct 2016."},{"key":"1580_CR18","volume-title":"The Elements of Statistical earning; Data Mining, Inference and Prediction","author":"T Hastie","year":"2009","unstructured":"Hastie T, Tibshirani R, Friedman J. The Elements of Statistical earning; Data Mining, Inference and Prediction. 2nd ed. New York: Springer Verlag; 2009.","edition":"2"},{"key":"1580_CR19","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2015","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2015. https:\/\/www.r-project.org\/ . Accessed 1 Oct 2016."},{"key":"1580_CR20","volume-title":"dplyr: A Grammar of Data Manipulation. R package version 0.4.3","author":"H Wickham","year":"2015","unstructured":"Wickham H, Francois R. dplyr: A Grammar of Data Manipulation. R package version 0.4.3. 2015. https:\/\/CRAN.R-project.org\/package=dplyr . Accessed 1 Oct 2016."},{"key":"1580_CR21","volume-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. 2010. https:\/\/www.jstatsoft.org\/article\/view\/v033i01 . Accessed 1 Oct 2016."},{"key":"1580_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.18553\/jmcp.2016.14261","volume":"22","author":"S Hopson","year":"2016","unstructured":"Hopson S, Saverno K, Liu LZ, AL-Sabbagh A, Orazem J, Costantino ME, et al. Impact of out-of-pocket costs on prescription fills among new initiators of biologic therapies for rheumatoid arthritis. J Manag Care Spec Pharm. 2016;22:122\u201330.","journal-title":"J Manag Care Spec Pharm"},{"key":"1580_CR23","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/art.39079","volume":"67","author":"J Yazdany","year":"2015","unstructured":"Yazdany J, Dudley RA, Chen R, Lin GA, Tseng CW. Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D. Arthritis Rheumatol. 2015;67:1474\u201380.","journal-title":"Arthritis Rheumatol"},{"key":"1580_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/nau.22602","volume":"34","author":"A Wagg","year":"2015","unstructured":"Wagg A, Gibson W, Ostaszkiewicz J, Johnson T, Markland A, Palmer MH, et al. Urinary incontinence in frail elderly persons: Report from the 5th International Consultation on Incontinence. Neurourol Urodyn. 2015;34:398\u2013406.","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"1580_CR25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.18553\/jmcp.2013.19.7.542","volume":"19","author":"PP Gleason","year":"2013","unstructured":"Gleason PP, Alexander GC, Starner CI, Ritter ST, Van Houten HK, Gunderson BW, et al. Health plan utilization and costs of specialty drugs within 4 chronic conditions. J Manag Care Pharm. 2013;19(7):542\u20138.","journal-title":"J Manag Care Pharm"},{"key":"1580_CR26","doi-asserted-by":"publisher","unstructured":"Galo JS, Mehat P, Rai SK, Avina-Zubieta A, De Vera MA. What are the effects of medication adherence interventions in rheumatic diseases: a systematic review. Ann Rheum Dis. 2016;75(4):667\u201373. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206593 .","DOI":"10.1136\/annrheumdis-2014-206593"},{"issue":"12","key":"1580_CR27","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/acr.22646","volume":"67","author":"MM Crane","year":"2015","unstructured":"Crane MM, Juneja M, Allen J, Kurrasch RH, Chu ME, Quattrocchi E, et al. Epidemiology and treatment of new-onset and established rheumatoid arthritis in an insured US population. Arthritis Care Res (Hoboken). 2015;67(12):1646\u201355.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"25","key":"1580_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1214\/10-STS330","volume":"3","author":"G Shmueli","year":"2010","unstructured":"Shmueli G. To explain or to predict? Stat Sci. 2010;3(25):289\u2013310.","journal-title":"Stat Sci"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1580-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1580-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1580-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T15:24:19Z","timestamp":1661095459000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1580-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1580-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"27 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board at the Johns Hopkins Bloomberg School of Public Health determined that the human subject research activity in this study meets the criteria for exemption under 45 CFR 46.101(b), Category (4) and thus waived the need for approval for this study (IRB No: 00007933). No consent to participate in this study from patients was needed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No consent for publication from patients was needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HJK, KD, PS, SS, HK, DB, and CTM declare that they have no competing interests. JRC receives salary support from the nonprofit Patient Centered Outcomes Research Institute (PCORI) for unrelated work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"79"}}